Fair Value Measurements and Long-term Investments (Tables)

6 Months Ended

Jun. 30, 2017

Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of the respective balance sheet dates:

	Balance Sheet	June 30, 2017										December 31, 2016
(In thousands)	Classifications	Level 1		Level 2		Level 3			Total			Level 1		Level 2		Level 3			Total
NantHealth Common Stock	Available for sale marketable securities	$	63,450	$	0	$	0		$	63,450		$	149,100	$	0	$	0		$	149,100
Non-marketable convertible note	Other assets		0		0		1,152			1,152			0		0		1,156			1,156
1.25% Call Option	Other assets		0		0		32,046			32,046			0		0		17,080			17,080
1.25% Embedded cash conversion option	Other liabilities		0		0		(32,931	)		(32,931	)		0		0		(17,659	)		(17,659	)
Foreign exchange derivative assets	Prepaid expenses and other current assets		0		2,054		0			2,054			0		1,021		0			1,021
Total		$	63,450	$	2,054	$	267		$	65,771		$	149,100	$	1,021	$	577		$	150,698

Schedule Of Long-term Equity And Cost Method Investments Table [Text Block]

The following table summarizes our long-term equity investments which are included in other assets in the accompanying consolidated balance sheets:

	Number of
	Investees		Original		Carrying Value at
(In thousands, except # of investees)	at June 30, 2017		Investment		June 30, 2017		December 31, 2016
Equity method investments ⁽¹⁾		3	$	1,658	$	3,693	$	2,436
Cost method investments		6		31,284		25,284		26,041
Total equity investments		9	$	32,942	$	28,977	$	28,477

⁽¹⁾

Allscripts share of the earnings of our equity method investees is reported based on a one quarter lag.